In May, an interdisciplinary MUSC research team won an inaugural Blue Sky Award, which provided $100,000 in funding for its project to restore vision in patients with age-related macular degeneration (AMD) by recharging the eye cells’ batteries. The Blue Sky Award was created to encourage high-risk, high-reward research that has the potential to make a profound impact on patient care but is unlikely to attract traditional funding due to the difficulties of the projects.
The team is led by Baerbel Rohrer, Ph.D., of the College of Medicine, and Andrew Jakymiw, Ph.D., of the College of Dental Medicine, and included their graduate students Kyrie Wilson and Charles Holjencin. Rohrer is the Endowed Chair of Gene and Pharmaceutical Treatment of Retinal Degenerative Disease. Jakymiw is an expert in developing cell-penetrating peptides for drug delivery.
Together, they intend…
